It will help speed up inoculationJohnson & Johnson’s (J&J) single-dose vaccine protects against COVID-19, according to an analysis by U.S. regulators on Wednesday that sets the stage for a final decision on a new and easier-to-use shot to help tame the pandemic. The Food and Drug Administration’s (FDA) scientists confirmed that overall the vaccine is about 66% effective at preventing moderate to severe COVID-19. The agency also said J&J’s shot — one that could help speed vaccinations by requiring just one dose instead of two — is safe to use. The FDA is expected to make a final decision within days. So far, about 44.5 million Americans have received at least one dose of the Pfizer or Moderna vaccines, and nearly 20 million have received the second.

Source: The Hindu February 24, 2021 16:18 UTC